Bicycle Therapeutics welcomes Dr. Roger Dansey and Hervé Hoppenot to its Board of Directors
– UK, Cambridge – Bicycle Therapeutics plc (NASDAQ: BCYC), a pharmaceutical company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide technology, announced the appointments of Dr.…